scholarly journals A tale of two embolisations

2013 ◽  
Vol 17 (2) ◽  
pp. 68-69
Author(s):  
Matthys Johannes Van Wyk ◽  
E Loggenberg

Chronic pulmonary tuberculosis may present as massive haemoptysis. Haemoptysis usually originates from the bronchial artery but the pulmonary artery might be the culprit vessel in recurrent haemoptysis. We present a case where bronchial artery embolisation had to be augmented by pulmonary artery coil embolisation for a Rasmussen's aneurysm after recurrent haemoptysis. In cases where recurrent haemorrhage occurs, sources other than the bronchial artery should be considered.

2020 ◽  
Vol 6 (1) ◽  
pp. 107-117
Author(s):  
Russell Frood ◽  
Shishir Karthik ◽  
Saeed Mirsadraee ◽  
Ian Clifton ◽  
Karen Flood ◽  
...  

2017 ◽  
Vol 6 (47) ◽  
pp. 3624-3628
Author(s):  
Siddharth Prakash ◽  
Kavita Saggar ◽  
Vikram Narang

2021 ◽  
Vol 8 (1) ◽  
pp. e000985
Author(s):  
Martha Dohna ◽  
Diane Miriam Renz ◽  
Florian Stehling ◽  
Christian Dohna-Schwake ◽  
Sivagurunathan Sutharsan ◽  
...  

IntroductionMassive haemoptysis is a life-threatening event in advanced cystic fibrosis (CF) lung disease with bronchial artery embolisation (BAE) as standard of care treatment. The aim of our study was to scrutinise short-term and long-term outcomes of patients with CF and haemoptysis after BAE using coils.MethodsWe carried out a retrospective cohort study of 34 adult patients treated for massive haemoptysis with super selective bronchial artery coil embolisation (ssBACE) between January 2008 and February 2015. Embolisation protocol was restricted to the culprit vessel(s) and three lobes maximum. Demographic data, functional end-expiratory volume in 1 s in % predicted (FEV1% pred.) and body mass index before and after ssBACE, sputum colonisation, procedural data, time to transplant and time to death were documented.ResultsPatients treated with ssBACE showed significant improvement of FEV1% pred. after embolisation (p=0.004) with 72.8% alive 5 years post-ssBACE. Mean age of the patients was 29.9 years (±7.7). Mean FEV1% pred. was 45.7% (±20.1). Median survival to follow-up was 75 months (0–125). Severe complication rate was 0%, recanalisation rate 8.8% and 5-year-reintervention rate 58.8%. Chronic infection with Pseudomonas aeruginosa was found in 79.4%, Staphylococcus areus in 50% and Aspergillus fumigatus in 47.1%.DiscussionssBACE is a safe and effective treatment for massive haemoptysis in patients with CF with good results for controlling haemostasis and excellent short-term and long-term survival, especially in severely affected patients with FEV<40% pred. We think the data of our study support the use of coils and a protocol of careful and prudent embolisation.


2021 ◽  
Vol 9 ◽  
Author(s):  
Huihui Zhu ◽  
Fangfang Lv ◽  
Ming Xu ◽  
Shunhang Wen ◽  
Yangming Zheng ◽  
...  

Bronchial artery-pulmonary artery fistula secondary to pulmonary tuberculosis is an important cause of hemoptysis in adults, but it's relatively rare in children. Bronchial artery-pulmonary artery fistulas are mostly congenital in children and may have no clinical manifestations in the early stage. Congenital bronchial artery-pulmonary fistula with pulmonary tuberculosis can lead to hemoptysis. From 2016 to 2020, two children with pulmonary tuberculosis complicated with bronchial artery and pulmonary artery fistula were admitted and treated in our hospital. We reminded pediatricians to pay attention to a variety of etiology combined with the possibility of children's hemoptysis.


Sign in / Sign up

Export Citation Format

Share Document